Belgium

Novo Holdings buys Catalent for $16. 5 billion; Sells 3 to Novo Nordisk for $11 billion

Novo Holdings, the asset manager of the foundation that controls Novo Nordisk, has agreed to acquire Catalent for $16. 5 billion. The customer will recoup two-thirds of that spend by promoting 3 of Catalent’s fill and finish sites to Novo Nordisk for $11 billion. The front.

Novo Holdings buys Catalent for $16. 5 billion; Sells 3 to Novo Nordisk for $11 billion Read More »